How Broad Market ETFs Like VTI Can Support Long-Term Portfolio Stability Diversification is overlooked by many investors, but it can be a powerful tool for building long-term wealth.
ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 1% Pre-Market Net product revenue in the fourth quarter surged 431% to $38.3 million, above estimates of $37.8 million, according to Fiscal.ai data
Palo Alto Networks Removed From Wedbush’s ‘Best Ideas List’ — Here’s Why According to TheFly, Wedbush’s Dan Ives cited investment price discipline as the reason for the removal of PANW from the list.
Why Did ACLX Stock Surge 80% In Pre-Market Today? Gilead Sciences announced an agreement to acquire Arcellx in a $7.8 billion deal.
You Don't Need to Buy Apple Stock. Here's Why The tech giant has been a big winner for years, but there's a simple reason why many investors can leave it out of their portfolios
SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December.
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts ImmunityBio announced that it has partnered with Biopharma and Cigalah and hopes to launch Anktiva across the broader Middle East and North Africa (MENA) region over time.
Lucid Reportedly Lays Off 12% Workforce Amid Gravity SUV Ramp-Up Techcrunch reported on Friday, citing an internal memo, that the layoffs are likely to impact hundreds of employees.
GE Stock On Track To Hit All-Time High: Morgan Stanley Calls It A ‘Structural Winner’, Flags 27% Upside Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.
Trevian Wealth Management Buys $2.7 Million of Fidelity Nasdaq Composite Index ETF Fidelity Nasdaq Composite Index ETF tracks thousands of U.S.-listed growth and technology stocks for broad market exposure.
JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale.
BKNG Stock Falls To Over 16-Month Lows – Brokerages Flag AI-Related Uncertainties Multiple brokerages, including Barclays and Oppenheimer, slashed their price targets despite a better-than-expected fourth quarter print.
This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened? PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.
CVNA Stock Slumps 10% Pre-Market: Wall Street Questions 2026 Visibility, Retail Flags ‘Deterioration’ Multiple brokerages slashed Carvana’s price target after the company’s fourth-quarter earnings fell below Street estimates.
Amazon Pips Walmart To Become World’s Biggest Company By Revenue Amazon reported revenue of $716.9 billion in the fiscal year 2025, while its retail rival Walmart posted $713.2 billion in revenue during the year.
